Evaluation of 29 Indicators for the Prognosis of Advanced Non-Small Cell Lung Cancer With Cytokine-Induced Killer Cell Therapy Combined With Chemotherapy

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2016.3102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

XPG Polymorphisms Are Associated With Prognosis of Advanced Non-Small Cell Lung Cancer Treated With Platinum-Based Doublet Chemotherapy

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

OA08 Efficacy and Safety of Sintilimab Combined With 1st Line Chemotherapy in Advanced Squamous Cell Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Adoptive Cell Therapy of Melanoma With Cytokine-Induced Killer Cells

Immune Network
Infectious DiseasesImmunologyAllergy
2015English

Eastern Cooperative Oncology Group Experience With Chemotherapy in Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1998English

Correlation of Neuroendocrine Features With Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Cytokine Release Syndrome With Pseudoprogression in a Patient With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy